Orange Book Warnings Highlight FTC's Drug Price Focus

By David McIntosh, Jacqueline Grise and Rachael Bacha · June 18, 2024, 2:47 PM EDT

Seizing yet another arrow in the Biden administration's quiver to combat what it sees as artificially high drug prices, the Federal Trade Commission continues its brigade against so-called junk Orange Book...

To view the full article, register now.